Literature DB >> 2008855

The epidemiology of impaired glucose tolerance and hypertension.

W B Kannel1, P W Wilson, T J Zhang.   

Abstract

Epidemiologic research indicates that glucose intolerance and hypertension are interrelated phenomena, each powerfully predisposing to atherosclerotic cardiovascular disease. Both diabetic and hypertensive patients have greater amounts of atherogenic risk factors, including dyslipidemia, hyperuricemia, elevated fibrinogen, and left ventricular hypertrophy. Diabetic persons have an increased prevalence of hypertension (50%), and glucose intolerance is more common in hypertension (15% to 18%). Both share a strong relationship to excess weight, but the excess of hypertension in diabetic persons occurs in both lean and obese subjects. Diabetes doubles the risk of hypertension associated with overweight. The risk of coronary disease, stroke, and peripheral arterial disease increases with increasing blood pressure to the same degree in diabetic persons as in nondiabetic persons, but at any level of blood pressure, diabetic persons have a doubled risk of these outcomes. Both diabetic and hypertensive patients are particularly prone to silent or unrecognized myocardial infarctions. Greater efforts at primary prevention of both hypertension and diabetes are clearly needed, including efforts at weight control, exercise, limitation of salt intake, and control of blood lipid levels. In either diabetic or hypertensive candidates for cardiovascular disease, optimization of the chances of avoiding sequelae requires a comprehensive multifactorial approach. Prevention requires more than normalization of either the blood sugar or blood pressure. Rational preventive measures must also include weight reduction, a fat-modified diet, cessation of smoking cigarettes, raising high-density lipoprotein, lowering low-density lipoprotein, and reduction of fibrinogen. Hypertension, obesity, insulin resistance, hyperinsulinemia, hypertriglyceridemia, and low high-density lipoprotein cholesterol tend to coexist.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008855     DOI: 10.1016/0002-8703(91)90432-h

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  30 in total

1.  Are Scots with hypertension at high risk of diabetes or impaired glucose tolerance?

Authors:  Jean Robson; Susan McGrouther
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

2.  Blood pressure reactions to insulin treatment in patients with type 2 diabetes.

Authors:  Sylvi U Persson
Journal:  Int J Angiol       Date:  2007

Review 3.  Blood pressure lowering in patients with diabetes--one level might not fit all.

Authors:  Rhonda M Cooper-DeHoff; Eric F Egelund; Carl J Pepine
Journal:  Nat Rev Cardiol       Date:  2010-11-16       Impact factor: 32.419

4.  Smoking prevalence and associated risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  S J Stachenko; B A Reeder; E Lindsay; C Donovan; R Lessard; C Balram
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

Review 5.  Benefit of Blood Pressure Control in Diabetic Patients.

Authors:  Ulrich Kintscher
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

Review 6.  The DASH diet and insulin sensitivity.

Authors:  Alan L Hinderliter; Michael A Babyak; Andrew Sherwood; James A Blumenthal
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 7.  Antihypertensive treatment and new-onset diabetes mellitus.

Authors:  Tonje Amb Aksnes; Henrik M Reims; Sverre E Kjeldsen; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 8.  What is the ideal blood pressure goal for patients with diabetes mellitus and nephropathy?

Authors:  Mark L Lipman; Ernesto L Schiffrin
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

9.  Could pre-diabetes be considered a clinical condition? opinions from an endocrinologist and a cardiologist.

Authors:  Maria Eliane C Magalhães; Breno A Cavalcanti; Saulo Cavalcanti
Journal:  Diabetol Metab Syndr       Date:  2010-01-15       Impact factor: 3.320

Review 10.  Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?

Authors:  Gianfranco Parati; Grzegorz Bilo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.